This study presents a valuable finding on the alterations in the autophagic-lysosomal pathway in a Huntington's disease model. The evidence supporting the claims of the authors is solid. However, the ...
As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
6d
News Medical on MSNUnlocking the potential of receptor-based approaches in diabetes treatmentAnnouncing a new article publication for BIO Integration journal. Diabetes, a common metabolic condition, poses a substantial health burden worldwide. To revolutionize diabetes management, enhance ...
Salon on MSN13d
Scientists find Ozempic may treat cancer, Alzheimer's and more. Is it hype or truly a "wonder drug?"Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...
Yale researchers found that cannabis-derived compounds CBD, CBG and CBN reduce pain signaling by inhibiting the Nav1.8 ...
Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...
Importantly, the study also connects endocan's actions to cMyc, a protein pivotal in many cancers but difficult to target directly. "Inhibiting ... Miriam and Sheldon G. Adelson Medical Research ...
Ministry of Health, Labour and Welfare to evaluate ACP as potential first and only treatment for patients with geographic atrophy (GA) secondary ...
A combination treatment has shown promise for treating a rare blood disease, according to a clinical trial published in the journal Blood.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results